Changes in plasma lipid species following pravastatin treatment predict cardiovascular outcomes and represent a measure of the relative risk reduction in secondary prevention
P Meikle, KS Jayawardana, PA Mundra, PJ Nestel, EH Barnes, A Kirby, P Thompson, DR Sullivan, ZH Alshehry, K Huynh, C Giles, IC Marschner, BA Kingwell, J Simes, AM Tonkin
EUROPEAN HEART JOURNAL | OXFORD UNIV PRESS | Published : 2018
Awarded by National Health and Medical Research Council of Australia
This work was funded by the National Health and Medical Research Council of Australia (grant number 1029754).